NO992676D0 - 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse - Google Patents

1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse

Info

Publication number
NO992676D0
NO992676D0 NO992676A NO992676A NO992676D0 NO 992676 D0 NO992676 D0 NO 992676D0 NO 992676 A NO992676 A NO 992676A NO 992676 A NO992676 A NO 992676A NO 992676 D0 NO992676 D0 NO 992676D0
Authority
NO
Norway
Prior art keywords
diazabicyclo
oct
preparation
therapeutic use
ylmethyl
Prior art date
Application number
NO992676A
Other languages
English (en)
Other versions
NO992676L (no
Inventor
Alistair Lochead
Samir Jegham
Alain Nedelec
Axelle Solignac
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO992676D0 publication Critical patent/NO992676D0/no
Publication of NO992676L publication Critical patent/NO992676L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO992676A 1996-12-04 1999-06-02 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse NO992676L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614847A FR2756563B1 (fr) 1996-12-04 1996-12-04 Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
PCT/FR1997/002174 WO1998024790A1 (fr) 1996-12-04 1997-12-02 Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-ylmethyle, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
NO992676D0 true NO992676D0 (no) 1999-06-02
NO992676L NO992676L (no) 1999-07-29

Family

ID=9498306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992676A NO992676L (no) 1996-12-04 1999-06-02 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse

Country Status (19)

Country Link
US (1) US6057321A (no)
EP (1) EP0942910A1 (no)
JP (1) JP2001504855A (no)
KR (1) KR20000069283A (no)
CN (1) CN1239962A (no)
AU (1) AU7624598A (no)
BG (1) BG103432A (no)
BR (1) BR9714215A (no)
CA (1) CA2271072A1 (no)
CZ (1) CZ193799A3 (no)
EE (1) EE9900218A (no)
FR (1) FR2756563B1 (no)
HU (1) HUP9904206A3 (no)
IL (1) IL129927A0 (no)
NO (1) NO992676L (no)
NZ (1) NZ336044A (no)
SK (1) SK74199A3 (no)
TR (1) TR199901068T2 (no)
WO (1) WO1998024790A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040085A2 (en) 1995-06-07 1996-12-19 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
JP4758336B2 (ja) * 2003-04-08 2011-08-24 チバ ホールディング インコーポレーテッド 顔料分散体における光安定化ポリマー分散剤
US7880683B2 (en) * 2004-08-18 2011-02-01 Ruckus Wireless, Inc. Antennas with polarization diversity
EP2138539B1 (en) 2007-04-16 2016-04-06 Daikin Industries, Ltd. Fluorine-containing elastomer composition and sealing material composed of the same
EP2197882A2 (de) * 2007-09-03 2010-06-23 Basf Se Verfahren zur herstellung von teda-derivaten
US20110077376A1 (en) * 2008-05-30 2011-03-31 Katsumi Tokumoto Process for producing hydroxyalkyltriethylenediamine, and catalyst composition for the production of polyurethane resin using it
CA2726202C (en) 2008-05-30 2016-09-27 Tosoh Corporation Process for producing hydroxyalkyltriethylenediamine, and catalyst composition for the production of polyurethane resin using it
CN101671336B (zh) * 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途
JP5504835B2 (ja) * 2009-11-13 2014-05-28 東ソー株式会社 ヒドロキシアルキルピペラジン類及び／又はヒドロキシメチルトリエチレンジアミン類の製造方法
JP5549847B2 (ja) * 2009-11-16 2014-07-16 東ソー株式会社 Ｎ−（２−アルコキシメチル）トリエチレンジアミン類の製造法
JP5707912B2 (ja) * 2010-12-08 2015-04-30 東ソー株式会社 Ｎ−（ジヒドロキシアルキル）ジエチレントリアミン類の組成物、及びそれを用いた２−ヒドロキシ（アルキル）トリエチレンジアミン類の製造方
JP6393959B2 (ja) 2012-05-31 2018-09-26 東ソー株式会社 ポリウレタン樹脂製造用触媒組成物及びそれを用いたポリウレタン樹脂の製造方法
JP6252152B2 (ja) * 2013-12-11 2017-12-27 東ソー株式会社 二環式アミン化合物の製造方法
KR20220055152A (ko) 2020-10-26 2022-05-03 인하대학교 산학협력단 급성 융모양막염 진단용 조성물 및 이를 이용한 급성 융모양막염 진단방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
TW282460B (no) * 1993-12-28 1996-08-01 Yamanouchi Pharma Co Ltd
FR2735475B1 (fr) * 1995-06-13 1997-07-11 Synthelabo Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
NZ336044A (en) 2000-03-27
EP0942910A1 (fr) 1999-09-22
HUP9904206A2 (hu) 2000-06-28
TR199901068T2 (xx) 1999-07-21
SK74199A3 (en) 2000-02-14
AU7624598A (en) 1998-06-29
US6057321A (en) 2000-05-02
BG103432A (en) 2000-06-30
BR9714215A (pt) 2000-04-18
KR20000069283A (ko) 2000-11-25
HUP9904206A3 (en) 2000-07-28
EE9900218A (et) 1999-12-15
JP2001504855A (ja) 2001-04-10
IL129927A0 (en) 2000-02-29
CN1239962A (zh) 1999-12-29
NO992676L (no) 1999-07-29
FR2756563B1 (fr) 1998-12-24
CA2271072A1 (fr) 1998-06-11
CZ193799A3 (cs) 1999-09-15
WO1998024790A1 (fr) 1998-06-11
FR2756563A1 (fr) 1998-06-05

Similar Documents

Publication Publication Date Title
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
NO985977D0 (no) Spiro-piperidinderivater og deres anvendelse som terapeutiske midler
NO954369D0 (no) Oksazolidindionderivater, deres fremstilling og anvendelse
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
ZA989556B (en) Benzoxazine derivatives their preparation and their therapeutic application
FI956298A0 (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
DK1000063T3 (da) 4-oxo-3,5-dihydro-4H-pyridazin[4,5-b]indol-1-acetamidderivater, fremstilling heraf og terapeutisk anvendelse heraf
NO953673L (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
NO20001934D0 (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
NO962477D0 (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
DK0835254T3 (da) Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
NO980471D0 (no) Benzensulfonamidderivater, fremstilling derav og terapautiske anvendelser derav
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
NO982549D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
NO950560L (no) Piperazinderivater, deres fremstilling og terapautiske anvendelse
NO990303D0 (no) Lipidbindende proteiner og deres terapeutiske og diagnostiske anvendelse
NO951812D0 (no) Pyrrolderivater, deres fremstilling og anvendelse
NO992436D0 (no) N(imidazolylbutyl)benzensulfonamidderivater, deres fremstilling og terapeutiske anvendelse
NO995966D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, deres fremstilling og terapeutisk anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application